IL84729A - Preparation of a vaccine against hepatitis b and the vaccine obtained thereby - Google Patents

Preparation of a vaccine against hepatitis b and the vaccine obtained thereby

Info

Publication number
IL84729A
IL84729A IL84729A IL8472987A IL84729A IL 84729 A IL84729 A IL 84729A IL 84729 A IL84729 A IL 84729A IL 8472987 A IL8472987 A IL 8472987A IL 84729 A IL84729 A IL 84729A
Authority
IL
Israel
Prior art keywords
vaccine
preparation
zonal
subjected
against hepatitis
Prior art date
Application number
IL84729A
Other languages
English (en)
Other versions
IL84729A0 (en
Original Assignee
Pasteur Vaccins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Vaccins filed Critical Pasteur Vaccins
Publication of IL84729A0 publication Critical patent/IL84729A0/xx
Publication of IL84729A publication Critical patent/IL84729A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL84729A 1986-12-10 1987-12-07 Preparation of a vaccine against hepatitis b and the vaccine obtained thereby IL84729A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8617265A FR2608052B1 (fr) 1986-12-10 1986-12-10 Procede de preparation d'un vaccin contre l'hepatite b et vaccin obtenu

Publications (2)

Publication Number Publication Date
IL84729A0 IL84729A0 (en) 1988-05-31
IL84729A true IL84729A (en) 1993-02-21

Family

ID=9341743

Family Applications (1)

Application Number Title Priority Date Filing Date
IL84729A IL84729A (en) 1986-12-10 1987-12-07 Preparation of a vaccine against hepatitis b and the vaccine obtained thereby

Country Status (11)

Country Link
EP (1) EP0273811B1 (de)
JP (1) JPS63215639A (de)
KR (1) KR880007732A (de)
AT (1) ATE109353T1 (de)
CA (1) CA1306689C (de)
DE (1) DE3750330T2 (de)
DK (1) DK645687A (de)
FR (1) FR2608052B1 (de)
IL (1) IL84729A (de)
NO (1) NO171147C (de)
PT (1) PT86321B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1073604A (zh) * 1991-12-01 1993-06-30 高真南 制备高免疫原性乙型肝炎疫苗的方法
WO1993012815A1 (fr) * 1991-12-27 1993-07-08 Gensci Limited Procede d'obtention d'un antigene de surface recombine de l'hepatite b, antigene et vaccin a base de celui-ci

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1356413A (en) * 1971-09-09 1974-06-12 Pfizer Ltd Method of obtaining purified australia antigen from blood serum
US4088748A (en) * 1976-11-02 1978-05-09 Merck & Co., Inc. Hepatitis B surface antigen
US4162192A (en) * 1978-09-28 1979-07-24 Juridical Foundation Method for purification of HBs antigen
FR2560890B1 (fr) * 1984-03-07 1987-10-16 Grp Genie Genetique Composition utile pour la fabrication de vaccins contenant des particules portant l'antigene de surface du virus de l'hepatite b et le recepteur de l'albumine serique humaine polymerisee, cellules animales capables de produire de telles particules et procede pour leur obtention
US4624918A (en) * 1984-07-09 1986-11-25 Genentech, Inc. Purification process for hepatitis surface antigen and product thereof
US4683294A (en) * 1985-04-03 1987-07-28 Smith Kline Rit, S.A. Process for the extraction and purification of proteins from culture media producing them

Also Published As

Publication number Publication date
IL84729A0 (en) 1988-05-31
EP0273811A3 (en) 1988-08-03
CA1306689C (en) 1992-08-25
DE3750330T2 (de) 1994-11-17
NO171147C (no) 1993-02-03
NO875142D0 (no) 1987-12-09
EP0273811B1 (de) 1994-08-03
DK645687A (da) 1988-06-11
EP0273811A2 (de) 1988-07-06
JPS63215639A (ja) 1988-09-08
PT86321B (pt) 1990-11-07
DE3750330D1 (de) 1994-09-08
DK645687D0 (da) 1987-12-09
NO875142L (no) 1988-06-13
FR2608052A1 (fr) 1988-06-17
KR880007732A (ko) 1988-08-29
ATE109353T1 (de) 1994-08-15
NO171147B (no) 1992-10-26
FR2608052B1 (fr) 1990-04-13
PT86321A (fr) 1988-01-01

Similar Documents

Publication Publication Date Title
DE3280468D1 (de) Synthese von menschlichen Virusantigenen durch Hefe.
EP0584348A4 (en) Genetic vaccine for immunodeficiency viruses
MA21911A1 (fr) Procede pour produire une grande proteine de surface modifiee du virus de l'hepatite b .
ATE59409T1 (de) Herstellung von oberflaechen-hepatitis-b-antigen in hefe.
DE3584866D1 (de) Hybridpartikel-immunogene.
FI102616B1 (fi) Menetelmä rokotteen valmistamiseksi ihmisen parainfluenssa-viruksen tyyppiä 3 varten ja menetelmässä käytettävä ilmentämisjärjestelmä
IL90035A (en) Synthetic multimeric hepatitis b virus vaccine including both t cell and b cell determinants
EP0231083A3 (en) Purification of pertussis antigens
IL84729A (en) Preparation of a vaccine against hepatitis b and the vaccine obtained thereby
ATE73349T1 (de) Hepatitisoberflaechenantigenpartikelvakzin.
EP0198299A3 (de) Verfahren zur Herstellung von Hepatitis-B-Oberflächenantigen enthaltenden Partikeln in neuer Form, die hoch immunogen sind
AU2865084A (en) Virus antigen, preparation process thereof and its utilisation in diagnostic and therapy (vaccine)
AU4817885A (en) Hepatitis B antigenic compositions and vaccines against hepatitis B derived therefrom
AU2403188A (en) Infectious bovine rhinotracheitis virus mutants, vaccines containing same, methods for the production of same and methods for the use of same
EP0480525A3 (en) Method for obtaining recombinant surface antigen of hepatitis b virus (hep b) of higher immunogenic capacity and use thereof in a vaccine preparation
PT69953A (en) Process for preparing a composition comprising a lyophilized herpes virus
Gerin et al. Recombinant DNA and synthetic peptide approaches to HBV vaccine development: Immunogenicity and protective efficacy in chimpanzees.
ATE53235T1 (de) Synthese von menschlichen viralen antigenen mit hilfe von hefe.
Stephenne Production in yeast and mammalian cells of the first recombinant DNA human vaccine against hepatitis B: A technical and immunological comparison.
Chumdermpadejsuk et al. Immunogenicity of recombinant DNA hepatitis B vaccine in Thai adults.
HE et al. Preliminary study on the influence of enhancer Ⅰ upon the immune response of HBV DNA vaccine
JPS57209298A (en) Recombinant dna, its preparation, and host transformed therewith
BR9705324C1 (pt) Método para produção de hbsag purificado para preparação de vacina e vacina recombinante contra a hepatite do tipo b

Legal Events

Date Code Title Description
RH Patent void